<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 6-Mos <FISCAL-YEAR-END> Dec-31-1997<F1> <PERIOD-END> Jun-30-1997 <CASH> 1493 <SECURITIES> 382 <RECEIVABLES> 2775<F2> <ALLOWANCES> 0 <INVENTORY> 1808 <CURRENT-ASSETS> 7540 <PP&E> 6783 <DEPRECIATION> 2808 <TOTAL-ASSETS> 14524 <CURRENT-LIABILITIES> 4865 <BONDS> 971 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 108 <OTHER-SE> 6709 <TOTAL-LIABILITY-AND-EQUITY> 14524 <SALES> 8109 <TOTAL-REVENUES> 8109 <CGS> 2175 <TOTAL-COSTS> 2175 <OTHER-EXPENSES> 1701 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 50 <INCOME-PRETAX> 2165 <INCOME-TAX> 617 <INCOME-CONTINUING> 1548 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1548 <EPS-PRIMARY> 1.55 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.